Indications And Dose
STALEVO ® 100/25/200 Parkinson’s disease and end-of-dose motor fluctuations not adequately controlled with levodopa and dopa- decarboxylase inhibitor treatment ▶BY MOUTH ▶Adult: 1 tablet for each dose; maximum 10 tablets per day STALEVO ® 125/31.25/200 Parkinson’s disease and end-of-dose motor fluctuations not adequately controlled with levodopa and dopa- decarboxylase inhibitor treatment ▶BY MOUTH ▶Adult: 1 tablet for each dose; maximum 10 tablets per day STALEVO ® 150/37.5/200 Parkinson’s disease and end-of-dose motor fluctuations not adequately controlled with levodopa and dopa- decarboxylase inhibitor treatment ▶BY MOUTH ▶Adult: 1 tablet for each dose; maximum 10 tablets per day STALEVO ® 175/43.75/200 Parkinson’s disease and end-of-dose motor fluctuations not adequately controlled with levodopa and dopa- decarboxylase inhibitor treatment ▶BY MOUTH ▶Adult: 1 tablet for each dose; maximum 8 tablets per day STALEVO ® 200/50/200 Parkinson’s disease and end-of-dose motor fluctuations not adequately controlled with levodopa and dopa- decarboxylase inhibitor treatment ▶BY MOUTH ▶Adult: 1 tablet for each dose; maximum 7 tablets per day STALEVO ® 50/12.5/200 Parkinson’s disease and end-of-dose motor fluctuations not adequately controlled with levodopa and dopa- decarboxylase inhibitor treatment ▶BY MOUTH ▶Adult: 1 tablet for each dose; maximum 10 tablets per day STALEVO ® 75/18.75/200 Parkinson’s disease and end-of-dose motor fluctuations not adequately controlled with levodopa and dopa- decarboxylase inhibitor treatment ▶BY MOUTH ▶Adult: 1 tablet for each dose; maximum 10 tablets per day
PDF page 458

